Table 1. Demographic and clinical data of subjects of the Stanley foundation neuropathology consortium used in this study.
| Control, N=15 | Schizophrenia, N=15 | Bipolar disorder, N=15 | Depression, N=15 | |
|---|---|---|---|---|
| Gender (M/F) | 9/6 | 9/6 | 9/6 | 9/6 |
| Age (year) | 48.1±10.7 | 44.5±13.1 | 42.3±11.7 | 46.5±9.3 |
| Post mortem interval (hour) | 23.7±9.9 | 33.7±14.6 | 32.5±16.1 | 27.5±10.7 |
| Brain pH | 6.27±0.24 | 6.16±0.26 | 6.18±0.23 | 6.18±0.21 |
| Brain hemisphere (R/L) | 7/8 | 6/9 | 8/7 | 6/9 |
| Brain weight (g) | 1501±164 | 1472±108 | 1441±172 | 1462±142 |
| Storage days | 338±234 | 621±233 | 621±172 | 434±290 |
| Age of onset (year) | — | 23.2±8.0 | 21.5±8.3 | 33.9±13.3 |
| Duration of illness (year) | — | 21.3±11.4 | 20.1±9.7 | 12.7±11.1 |
| History of psychosis | 0 | 15 | 11 | 0 |
| Suicide death | 0 | 4 | 9 | 7 |
| Lifetime fluphenazine equivalent (mg) | — | 52 270±62 060 | 20 830±24 020 | — |
| Drug use | ||||
| Little/none | 14 | 10 | 7 | 10 (1 N/A) |
| Social | 1 | |||
| Moderate use, past | 1 | 1 | ||
| Moderate use, present | 1 | 5 | ||
| Heavy use, past | 2 | 1 | 1 | |
| Heavy use, present | 1 | 2 | 2 | |
| Alcohol use | ||||
| Little/none | 5 | 5 | 1 (1 N/A) | 5 |
| Social (1–2 drinks/day) | 6 | 3 | 4 | 5 |
| Moderate use, past | 2 | 2 | 1 | 0 |
| Moderate use, present | 2 | 2 | 2 | 1 |
| Heavy use, past | 0 | 2 | 3 | 1 |
| Heavy use, present | 0 | 1 | 3 | 3 |
Abbreviations: M/F, male/female; R/L, right or left; N/A, not available.